Clinical Trials Directory

Trials / Completed

CompletedNCT00852865

Lactobacillus Farciminis and Hyperalgesia

Effect of a Dialy Consumption of a Probiotic (Lactobacillus Farciminis) on Hyperalgesia in Response to Thermal Stimulation

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Lallemand SAS · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Conditions

Interventions

TypeNameDescription
DRUGLactobacillus farciminis1 capsule per day. Each capsule containing 4\*109 CFU
DRUGPlacebo1 capsule per day

Timeline

Start date
2009-02-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2009-02-27
Last updated
2009-05-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00852865. Inclusion in this directory is not an endorsement.

Lactobacillus Farciminis and Hyperalgesia (NCT00852865) · Clinical Trials Directory